We are live on ! Find out more
HCPC

Hamilton Capital Partners (Canada) Portfolio holdings

AUM $3.45B
1-Year Est. Return 58.23%
This Fund
S&P 500
This Quarter Est. Return
+4.88%
1 Year Est. Return
+58.23%
3 Year Est. Return
+142.85%
5 Year Est. Return
10 Year Est. Return
AUM
$934M
AUM Growth
+$107M
Cap. Flow
+$75.8M
Cap. Flow %
8.12%
Top 10 Hldgs %
33.97%
Holding
174
New
17
Increased
90
Reduced
31
Closed

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$546K
2
MS icon
Morgan Stanley
MS
+$536K
3
AMGN icon
Amgen
AMGN
+$524K
4
APO icon
Apollo Global Management
APO
+$262K
5
MET icon
MetLife
MET
+$261K

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 13.97%
3 Financials 11.55%
4 Materials 8.48%
5 Communication Services 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNV icon
51
Franco-Nevada
FNV
$45.2B
$5.43M 0.58%
45,800
+5,905
+15% +$718K
ISRG icon
52
Intuitive Surgical
ISRG
$139B
$5.31M 0.57%
11,930
+666
+6% +$265K
EDV icon
53
Vanguard World Funds Extended Duration ETF
EDV
$3.45B
$5.21M 0.56%
70,991
+7,687
+12% +$556K
REGN icon
54
Regeneron Pharmaceuticals
REGN
$82.7B
$5.19M 0.56%
4,939
+270
+6% +$262K
BSX icon
55
Boston Scientific
BSX
$75.1B
$5.16M 0.55%
67,021
+374
+0.6% +$27.4K
GFI icon
56
Gold Fields
GFI
$36B
$5.12M 0.55%
343,360
+44,280
+15% +$719K
ELV icon
57
Elevance Health
ELV
$86.8B
$5M 0.54%
9,231
+514
+6% +$272K
VRTX icon
58
Vertex Pharmaceuticals
VRTX
$128B
$4.94M 0.53%
10,546
-154
-1% -$66.8K
BTG icon
59
B2Gold
BTG
$6.79B
$4.93M 0.53%
1,826,953
+235,710
+15% +$636K
PFE icon
60
Pfizer
PFE
$153B
$4.81M 0.52%
171,976
+9,704
+6% +$267K
DHR icon
61
Danaher
DHR
$142B
$4.74M 0.51%
18,961
+1,062
+6% +$268K
MRK icon
62
Merck
MRK
$335B
$4.58M 0.49%
37,005
+497
+1% +$64K
AMGN icon
63
Amgen
AMGN
$225B
$4.54M 0.49%
14,529
-1,784
-11% -$524K
ABBV icon
64
AbbVie
ABBV
$441B
$4.54M 0.49%
26,445
+1,486
+6% +$246K
SYK icon
65
Stryker
SYK
$130B
$4.5M 0.48%
13,220
+738
+6% +$250K
TMO icon
66
Thermo Fisher Scientific
TMO
$218B
$4.49M 0.48%
8,111
+450
+6% +$258K
SBSW icon
67
Sibanye-Stillwater
SBSW
$7.62B
$4.48M 0.48%
1,029,244
+132,780
+15% +$657K
MDT icon
68
Medtronic
MDT
$117B
$4.33M 0.46%
54,973
+2,230
+4% +$183K
CI icon
69
Cigna
CI
$74.7B
$4.31M 0.46%
13,028
+445
+4% +$153K
ABT icon
70
Abbott
ABT
$193B
$4.25M 0.45%
40,863
+2,296
+6% +$243K
BMY icon
71
Bristol-Myers Squibb
BMY
$130B
$3.75M 0.4%
90,186
+5,086
+6% +$228K
CVS icon
72
CVS Health
CVS
$124B
$3.59M 0.38%
60,806
+3,420
+6% +$214K
SCHO icon
73
Schwab Short-Term US Treasury ETF
SCHO
$13B
$3.28M 0.35%
136,358
+6,576
+5% +$158K
WFC icon
74
Wells Fargo
WFC
$269B
$3.01M 0.32%
50,642
+2,572
+5% +$152K
C icon
75
Citigroup
C
$234B
$2.97M 0.32%
46,854
+8,976
+24% +$553K

Similar funds

Hamilton Capital Partners (Canada)'s Q2 2024 Portfolio in Review

As of Q2 2024, Hamilton Capital Partners (Canada) held 174 positions worth $934M, up 13% from $826M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Hamilton Capital Partners (Canada) deployed $75.8M of net new capital in Q2 2024, opening 17 new positions and adding to 90 existing holdings. Its largest new stake was CoStar Group: 5,902 shares worth $438K.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Chevron, an estimated $546K trimmed.

  • Hamilton Capital Partners (Canada)'s largest Q2 2024 buy was CoStar Group: 5,902 shares worth $438K.
  • Hamilton Capital Partners (Canada) added most to iShares 20+ Year Treasury Bond ETF in Q2 2024, an estimated $4.09M increase.
  • Hamilton Capital Partners (Canada)'s biggest Q2 2024 reduction was Chevron, cutting an estimated $546K.
  • Hamilton Capital Partners (Canada)'s ten largest holdings make up 34% of its $934M portfolio in Q2 2024.
  • Hamilton Capital Partners (Canada) opened 17 new positions and closed 0 in Q2 2024.
  • Hamilton Capital Partners (Canada)'s portfolio value rose 13% quarter-over-quarter to $934M.

Based on Hamilton Capital Partners (Canada)'s 13F filing for Q2 2024, filed 14 Aug 2026.